Loading clinical trials...
Loading clinical trials...
This study reviews post study clinical endoscopy reports in follow up to patients who participated in MAY2016-07-01 with weekly erlotinib for familial adenomatous polyposis. Reviewing follow up medica...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
National Cancer Institute (NCI)
NCT03050268 · Acute Leukemia, Adenomatous Polyposis, and more
NCT06950385 · Familial Adenomatous Polyposis (FAP)
NCT06641310 · Familial Adenomatous Polyposis
NCT06578637 · FAP, Familial Adenomatous Polyposis
NCT06538402 · Ulcerative Colitis, Familial Adenomatous Polyposis
Mayo Clinic in Rochester
Rochester, Minnesota
M D Anderson Cancer Center
Houston, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions